TWiV 716: COVID-19 clinical update #48 with Dr. Daniel Griffin

February 6, 2021

In COVID-19 clinical update #48, Daniel Griffin reviews effect of spike amino acid changes on neutralization with monoclonal antibodies, Sputnik V safety and efficacy results, increased reactogenicity after a single vaccine dose in seropositive individuals, single dose vaccination in seropositive health care workers, and results of three clinical trials on the use of anticoagulants.

Hosts: Daniel Griffin and Vincent Racaniello

Click arrow to play
Download TWiV 716 (31 MB .mp3, 52 min)
Subscribe (free): iTunesGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

One comment on “TWiV 716: COVID-19 clinical update #48 with Dr. Daniel Griffin

  1. Sheri Bergen Feb 6, 2021

    Thank you for TWIV!
    I am a layperson and regular listener to TWIV and it has helped me get through this past year. Last year a colleague shared information on preparing one’s immune system to combat the virus from Eastern Virginia Medical School. Are you aware of these suggestions and is there any science to support them?

    Sheryl Bergen